Ravi Rao
Director/Board Member at DBV TECHNOLOGIES
Ravi Rao active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DBV TECHNOLOGIES | Director/Board Member | 18/05/2021 | - |
| Independent Dir/Board Member | 18/05/2021 | - | |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 31/03/2024 | - |
| The Royal College of Physicians | Corporate Officer/Principal | - | - |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 31/03/2022 | - |
Career history of Ravi Rao
Former positions of Ravi Rao
| Companies | Position | Start | End |
|---|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 17/08/2020 | 31/12/2021 |
| SPYRE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 03/11/2019 | 09/08/2020 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 31/08/2016 | 30/09/2019 |
| Corporate Officer/Principal | 31/03/2012 | 31/08/2016 | |
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 28/02/2022 | - |
Training of Ravi Rao
| University of Cambridge | Undergraduate Degree |
| Imperial College London | Doctorate Degree |
Statistics
International
| United Kingdom | 8 |
| United States | 2 |
| Sweden | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 2 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 6 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| DBV TECHNOLOGIES | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Private companies | 1 |
|---|---|
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Ravi Rao
- Experience
